Psyence Biomedical Ltd. (PBM) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Previous Close | 2.72 |
| Open | 2.71 |
| Day High | 3.09 |
| Day Low | 2.71 |
| 52-Week High | 468.36 |
| 52-Week Low | 1.92 |
| Volume | 59,768 |
| Average Volume | 2.62M |
| Market Cap | 56,486 |
| PE | -0.01 |
| EPS | -393.1 |
| Moving Average 50 Days | 4.99 |
| Moving Average 200 Days | 44.37 |
| Change | 0.25 |
Pacific Bay Announces Sale of Sphinx Property, Critical Minerals Impact at Haskins-Reed and Financing Update
Newsfile
Nov 18, 2025 9:00 PM GMT
Vancouver, British Columbia--(Newsfile Corp. - November 18, 2025) - David H. Brett, Chairman of Pacific Bay Minerals Ltd. (TSXV: PBM) ("Pacific Bay" or the "Company") is pleased to announce several corporate initiatives including the sale of its 100%
Pacific Bay Announces Non-Brokered Financing
Newsfile
Sep 25, 2025 8:33 PM GMT
Vancouver, British Columbia--(Newsfile Corp. - September 25, 2025) - David H. Brett, Chairman of Pacific Bay Minerals Ltd. (TSXV: PBM) ("Pacific Bay" or the "Company") reports that the Company is pleased to announce a non-brokered private placement o
Psyence BioMed Chief of Global Impact to Speak at Psychedelic Science 2025
Newsfile
Jun 18, 2025 12:30 PM GMT
Investors, Entrepreneurs, and Industry Experts to Convene at the Premier Psychedelic Science Business Forum hosted by Multidisciplinary Association for Psychedelic Studies (MAPS)Denver, Colorado--(Newsfile Corp. - June 18, 2025) - Psyence Biomedical